POS-769 ALLOGRAFT OUTCOMES, SAFETY AND EFFICACY OF QUINOLONE BASED AND RIFAMPIN BASED REGIMENS FOR THE TREATMENT OF TUBERCULOSIS IN KIDNEY TRANSPLANT RECIPIENTS

Among patients with kidney transplant receiving rifampicin-based anti-tuberculosis treatment regimen, the need for increased dose of immunosuppressants along with frequent drug level monitoring, imposes significant financial and economic burden in this disadvantaged population, more so in the middle- or low-income countries. However, as yet there are no prospective randomised studies comparing the efficacy of levofloxacin-based anti-tuberculosis treatment with rifampicin-based anti-tuberculosis treatment in kidney transplant recipients.